Affinity Asset Advisors, LLC
CIK 1773195
13F filing for Q2 2026・No. 1,535
- Holdings
- US$2.21B
- Quarter change
- +US$276.16M
- Entries
- 113
- Net bought (estimate)
- +US$15.5M
The quarter change is the holdings' value against the quarter before, price moves included — not what was bought or sold; each institution's page estimates that.
Net bought (estimate)
Each stock's change in shares at the quarter-end price, added up: a new position counts as bought, one sold out as sold, shares held long only. Splits are compared split-adjusted; corporate actions under a new CUSIP are not estimated. An estimate from the filings, not actual trades.
- New 18
- Sold out 9
- Cut 25
- Added 34
- Corporate actions 0
- Unchanged 24
Largest holdings
101 stocks worth US$2.02B, options and bonds left out.
| Stock | This quarter | Shares | Value | Weight |
|---|---|---|---|---|
| ROIVROIVANT SCIENCES LTDSHS | Added | 3,750,000 | US$132.71M | 6.58% |
| APGEAPOGEE THERAPEUTICS INCCOM | Cut | 987,000 | US$131M | 6.50% |
| SYRESPYRE THERAPEUTICS INCCOM NEW | Unchanged | 1,279,134 | US$113.56M | 5.63% |
| XENEXENON PHARMACEUTICALS INCCOM | Cut | 1,595,000 | US$96.27M | 4.77% |
| ERASCA INCCOM | Cut | 5,250,000 | US$96.18M | 4.77% |
| INSMINSMED INCCOM PAR $.01 | Added | 650,000 | US$69.3M | 3.44% |
| PRAXIS PRECISION MEDICINES ICOM NEW | Added | 185,000 | US$61.94M | 3.07% |
| ALKSALKERMES PLCSHS | Cut | 1,125,000 | US$58.94M | 2.92% |
| ORUKA THERAPEUTICS INCCOM | Added | 590,000 | US$56.15M | 2.78% |
| ANAPTYSBIO INCCOM | Cut | 826,109 | US$55.76M | 2.77% |
Sign in (free) to see its 50 largest holdings and its trades. Sign in
Filings
The quarter's original 13F filings (SEC).
- 13F-HRFiled August 13, 2026SEC ↗
13F covers long positions in US-listed securities only; the data is SEC's, filed within 45 days of the quarter's end.